How is Pandorum Technologies pioneering regenerative medicine in India?

Pandorum Technologies, founded in 2011 by Dr. Tuhin Bhowmick and Dr. Arun Chandru, is at the forefront of India’s regenerative‑medicine scene through its proprietary 3D‑bioprinting platform. The company has successfully developed functional, lab‑grown human tissues—most notably corneal and liver constructs—using bio‑ink formulations tailored to India’s regulatory and cost landscape. These tissues serve both as therapeutic grafts (e.g., corneal patches for vision restoration) and as high‑fidelity in‑vitro models that allow pharma companies to test drug toxicity more ethically and accurately than with animal studies. By combining advanced materials science, cell biology, and automation, Pandorum is reducing time‑to‑clinic and making tissue engineering more affordable, positioning India as a global contender in regenerative medicine.

Visit: https://startupsonrise.com/pandorum-tech...icine-in-india/